Duque-Estrada Bruna, Vincenzi Colombina, Misciali Cosimo, Tosti Antonella
Instituto de Dermatologia Prof. Rubem David Azulay, Rio de Janeiro, Brazil.
J Am Acad Dermatol. 2009 Oct;61(4):707-9. doi: 10.1016/j.jaad.2008.11.896. Epub 2009 Jul 3.
Mesotherapy has recently become an advertised method for the treatment of different types of alopecia despite the lack of any data regarding its efficacy and possible side effects. The substances injected into the scalp include "cocktails" of natural plant extracts, homoeopathic agents, vitamins, vasodilators, and drugs that may stimulate hair growth, such as finasteride and minoxidil. We report two cases of patchy alopecia that developed after mesotherapy for the treatment of androgenetic alopecia. In the first patient, alopecia developed after injections of the heparinoid vasodilator mesoglycan; the 3-month follow-up examination revealed a small residual area of cicatricial alopecia. The second patient developed reversible alopecia after multiple scalp injections of homeopathic agents. These cases underline the possible risks of mesotherapy as a therapeutic technique for hair loss.
尽管缺乏关于其疗效和可能副作用的任何数据,但中胚层疗法最近已成为一种用于治疗不同类型脱发的宣传方法。注射到头皮的物质包括天然植物提取物、顺势疗法药物、维生素、血管扩张剂以及可能刺激头发生长的药物,如非那雄胺和米诺地尔。我们报告了两例在接受中胚层疗法治疗雄激素性脱发后出现的斑秃病例。在第一例患者中,注射类肝素血管扩张剂硫酸乙酰肝素后出现脱发;3个月的随访检查发现有一小片瘢痕性脱发残留区域。第二例患者在多次头皮注射顺势疗法药物后出现可逆性脱发。这些病例突显了中胚层疗法作为一种脱发治疗技术可能存在的风险。